Tabrecta 200 mg film-coated tablets

DRUG2 trials

Sponsors

Oslo University Hospital HF, Institut National De La Sante Et De La Recherche Medicale

Conditions

CancerUnresectable locally advanced and/or metastatic soft-tissue sarcoma

Phase 2

Improving public cancer care by implementing precision medicine in Norway A multi-cohort phase 2 treatment clinical study investigating efficacy of approved drugs outside indication in patients with advanced cancer. IMPRESS-Norway

RecruitingCTIS2023-507894-16-00

Oslo University Hospital HFCancer

Start: 2021-04-01Target: 6000Updated: 2026-01-22

Phase 3

MULTISARC : MOLECULAR PROFILING OF ADVANCED SOFT-TISSUE SARCOMAS. A phase III study

RecruitingCTIS2024-514873-22-00

Institut National De La Sante Et De La Recherche MedicaleUnresectable locally advanced and/or metastatic soft-tissue sarcoma

Start: 2019-10-16Target: 960Updated: 2025-11-26